Gary Ingenito - 27 Nov 2024 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Med. & Reg. Officer
Signature
/s/ Gary Ingenito
Issuer symbol
CPRX
Transactions as of
27 Nov 2024
Net transactions value
-$224,534
Form type
4
Filing time
29 Nov 2024, 20:09:20 UTC
Previous filing
25 Nov 2024
Next filing
11 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $48,120 +12,000 +23% $4.01 63,391 27 Nov 2024 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $196,269 -8,631 -14% $22.74 54,760 27 Nov 2024 Direct F1
transaction CPRX Common stock, par value $0.001 per share Sale $76,385 -3,369 -6.2% $22.67 51,391 27 Nov 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -12,000 -1.1% $0.000000 1,041,631 27 Nov 2024 Common Stock 12,000 $4.01 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
F2 Options vested in three annual tranches beginning on January 2, 2019.